☰

susana mato - Publications

Affiliations: 
Univ P Vasco, Leioa, Euskadi, Spain 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Manterola A, Chara JC, Aguado T, Palazuelos J, Matute C, Mato S. Cannabinoid CB receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse. Frontiers in Neuroanatomy. 16: 1030060. PMID 36387996 DOI: 10.3389/fnana.2022.1030060  0.323
2020 Huerga-Gómez A, Aguado T, Sánchez-de la Torre A, Bernal-Chico A, Matute C, Mato S, Guzmán M, Galve-Roperh I, Palazuelos J. Δ -Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo. Glia. PMID 32956517 DOI: 10.1002/Glia.23911  0.39
2018 Canedo-Antelo M, Serrano MP, Manterola A, Ruiz A, Llavero F, Mato S, Zugaza JL, Pérez-Cerdá F, Matute C, Sánchez-Gómez MV. Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade. Frontiers in Molecular Neuroscience. 11: 333. PMID 30271323 DOI: 10.3389/Fnmol.2018.00333  0.381
2018 Manterola A, Bernal-Chico A, Cipriani R, Ruiz A, Pérez-Samartín A, Moreno-Rodríguez M, Hsu KL, Cravatt B, Brown JM, Rodríguez-Puertas R, Matute C, Mato S. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis. Neuropharmacology. PMID 30171986 DOI: 10.1016/J.Neuropharm.2018.08.038  0.684
2018 Mato S, Pilar-Cuéllar F, Valdizán EM, González-Maeso J, Rodríguez-Puertas R, Meana J, Sallés J, Crespo-Facorro B, Pazos Á. Selective up-regulation of cannabinoid CB receptor coupling to Go-proteins in suicide victims with mood disorders. Biochemical Pharmacology. PMID 30099006 DOI: 10.1016/J.Bcp.2018.08.012  0.732
2018 Manterola A, Bernal-Chico A, Cipriani R, Canedo-Antelo M, Moreno-García Á, Martín-Fontecha M, Pérez-Cerdá F, Victoria Sánchez-Gómez M, Ortega-Gutiérrez S, Mark Brown J, Hsu KL, Cravatt B, Matute C, Mato S. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination. Biochemical Pharmacology. PMID 30075103 DOI: 10.1016/J.Bcp.2018.07.042  0.352
2016 Gomis-González M, Matute C, Maldonado R, Mato S, Ozaita A. Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. Genes. 7. PMID 27589806 DOI: 10.3390/Genes7090056  0.404
2016 Borralleras C, Mato S, Amédée T, Matute C, Mulle C, Pérez-Jurado LA, Campuzano V. Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome. Molecular Brain. 9: 76. PMID 27485321 DOI: 10.1186/S13041-016-0258-7  0.391
2015 Bernal-Chico A, Canedo M, Manterola A, Victoria Sánchez-Gómez M, Pérez-Samartín A, Rodríguez-Puertas R, Matute C, Mato S. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. Glia. 63: 163-76. PMID 25130621 DOI: 10.1002/Glia.22742  0.69
2013 Busquets-Garcia A, Gomis-González M, Guegan T, Agustín-Pavón C, Pastor A, Mato S, Pérez-Samartín A, Matute C, de la Torre R, Dierssen M, Maldonado R, Ozaita A. Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nature Medicine. 19: 603-7. PMID 23542787 DOI: 10.1038/Nm.3127  0.463
2013 Mato S, Sánchez-Gómez MV, Bernal-Chico A, Matute C. Cytosolic zinc accumulation contributes to excitotoxic oligodendroglial death. Glia. 61: 750-64. PMID 23440871 DOI: 10.1002/Glia.22470  0.38
2013 Domercq M, Mato S, Soria FN, Sánchez-gómez MV, Alberdi E, Matute C. Zn2+ -induced ERK activation mediates PARP-1-dependent ischemic-reoxygenation damage to oligodendrocytes. Glia. 61: 383-93. PMID 23281060 DOI: 10.1002/Glia.22441  0.313
2011 Lafourcade M, Larrieu T, Mato S, Duffaud A, Sepers M, Matias I, De Smedt-Peyrusse V, Labrousse VF, Bretillon L, Matute C, Rodríguez-Puertas R, Layé S, Manzoni OJ. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nature Neuroscience. 14: 345-50. PMID 21278728 DOI: 10.1038/Nn.2736  0.746
2010 Mato S, Victoria Sánchez-Gómez M, Matute C. Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes. Glia. 58: 1739-47. PMID 20645411 DOI: 10.1002/Glia.21044  0.348
2010 Mato S, Vidal R, Castro E, Díaz A, Pazos A, Valdizán EM. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine 1A receptor-dependent mechanisms. Molecular Pharmacology. 77: 424-34. PMID 19995940 DOI: 10.1124/Mol.109.060079  0.626
2009 Mato S, Alberdi E, Ledent C, Watanabe M, Matute C. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes. Glia. 57: 295-306. PMID 18814177 DOI: 10.1002/Glia.20757  0.418
2008 Mato S, Lafourcade M, Robbe D, Bakiri Y, Manzoni OJ. Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens. Neuropharmacology. 54: 87-94. PMID 17606273 DOI: 10.1016/J.Neuropharm.2007.04.014  0.711
2007 Mato S, Aso E, Castro E, Martín M, Valverde O, Maldonado R, Pazos A. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors. Journal of Neurochemistry. 103: 2111-20. PMID 17944876 DOI: 10.1111/J.1471-4159.2007.04961.X  0.536
2007 Lafourcade M, Elezgarai I, Mato S, Bakiri Y, Grandes P, Manzoni OJ. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. Plos One. 2: e709. PMID 17684555 DOI: 10.1371/Journal.Pone.0000709  0.769
2005 Mato S, Robbe D, Puente N, Grandes P, Manzoni OJ. Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 11619-27. PMID 16354920 DOI: 10.1523/Jneurosci.2294-05.2005  0.739
2004 Fourgeaud L, Mato S, Bouchet D, Hémar A, Worley PF, Manzoni OJ. A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6939-45. PMID 15295029 DOI: 10.1523/Jneurosci.0671-04.2004  0.748
2004 Mato S, Chevaleyre V, Robbe D, Pazos A, Castillo PE, Manzoni OJ. A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nature Neuroscience. 7: 585-6. PMID 15146190 DOI: 10.1038/Nn1251  0.75
2004 Mato S, Pazos A. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain. Neuropharmacology. 46: 716-26. PMID 14996549 DOI: 10.1016/J.Neuropharm.2003.11.004  0.586
2003 Mato S, Del Olmo E, Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. The European Journal of Neuroscience. 17: 1747-54. PMID 12752773 DOI: 10.1046/J.1460-9568.2003.02599.X  0.701
2002 Mato S, Pazos A, Valdizán EM. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain. European Journal of Pharmacology. 443: 43-6. PMID 12044790 DOI: 10.1016/S0014-2999(02)01575-3  0.591
Show low-probability matches.